Innovative drug infusion technology for laboratory animals.

Japanese English
resources
SMP-310R SMP-200 null null null null null null null null

News

  • NewsNot ready to contact us yet but very interested to learn more through peer reviewed publications and webinars?

    Ask for our eBOOK or download directly from Linkedin (https://www.linkedin.com/feed/update/urn:li:activity:7518111416176807938)

    Our eBook has been updated with the latest publications and webinars links updated.
    You can also learn more at SfN2026 in Washington DC with discussions at the meeting.
    Booth 1114 Harvard Bioscience (DSI) and Booth 1623 Lafayette Life Sciences (ALZET LLC)

    November 6, 2026

  • NewsLooking to learn how Kleeman et al. used iPRECIO implantable, programmable and refillable pumps and ALZET LLC’s osmotic pump in their recent publication in Nature which was published 25th March 2026?

    Kleeman, S. O., Michalski, K., Zhao, X., Steigerwald, R., Ferrer, M., Levett, L., ... & Janowitz, T. (2026). Ectopic NMDAR expression in cancer unmasks germline-encoded autoimmunity. Nature, 1-13.
    https://www.nature.com/articles/s41586-026-10278-0

    May 11, 2026

  • NewsWant to learn more about the capabilities of iPRECIO Programmable Pumps via highlights from Peer Reviewed publications? Our updated eBook is available now. Includes our latest on-demand webinar and slide deck details from Dr. Jamie Oliver, Chief Medical Officer of Starton Therapeutics available on Labroots. Results from 3 different studies with iPRECIO pumps were shared in the webinar. Contact us directly via email, Contact Us Form or download from Linkedin. We are to help.

    Feburary 17, 2026

  • NewsWant to learn more about the capabilities of iPRECIO Programmable Pumps via highlights from Peer Reviewed publications? Our updated eBook is available now. Contact us directly via email, Contact Us Form or download from Linkedin. We are to help.

    Feburary 9, 2026

  • NewsBenson et al. (2026) addressed a potential circadian confound – the time of day when infusion pumps were implanted – by using programmable iPRECIO pumps to standardize drug delivery timing across subjects, illustrating a proactive approach to experimental design

    Benson, Lance N., et al. "Time of Day Drives Angiotensin II–Dependent Hypertension."
    Hypertension 83.2 (2026): e25906.
    https://www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.125.25906
    https://pmc.ncbi.nlm.nih.gov/articles/PMC12826273/

    January 26, 2026

Our Mission with
iPRECIO® Product Portfolio:


Make it as easy as possible to evaluate efficacy of molecules/agents in different animal models and species.

Make the results as relevant as possible to the clinic. (Exposure profile, quantitative pharmacology, untethered free moving (stress free, group housing (socialization), ..…)


The use of iPRECIO® pumps will have a positive impact on experimental conditions and the relevance of results achieved. Initial costs maybe higher but in the long run the use of the pump could be cost saving in the context of the whole compound development.




Download NEW Resources eBook

Page top

logo
Privacy Policy